Gemmes reaps €12m in Asten partial exit

Following the deal, Gemmes remains the majority shareholder of Asten, alongside several investment associations. The buyer and existing shareholder, Salvepar, increased its stake in the business to 22.3%.

The fresh funding will enable the business to consolidate its market and boost its product development in the telemedicine segment.

Previous funding
Salvepar first acquired a 14.6% stake in Asten from Gemmes in 2014. The deal was valued at €16m.

Company
Asten is a French homecare provider operating in both the voluntary and professional sectors. The business is based in Ivry-sur-Seine, France.

The company specialises in oxygen therapy and services relating to drip, nutrition and insulin-therapy.

People
Gemmes Venture – Philippe Monnot (founder, CEO).

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Exits
• Healthcare
• France
• France